Novo Nordisk A/S
NVO
$126.85
$1.060.84%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 69.83% | 68.26% | 48.88% | 33.16% | 11.49% |
| Total Depreciation and Amortization | -33.23% | 33.40% | 35.80% | -0.51% | -21.14% |
| Total Amortization of Deferred Charges | 14.80% | -- | -- | -- | -12.89% |
| Total Other Non-Cash Items | 48.98% | -75.37% | 128.00% | 202.83% | -44.25% |
| Change in Net Operating Assets | -3,204.13% | 214.28% | -200.21% | -615.38% | 97.43% |
| Cash from Operations | 41.36% | 82.24% | 21.72% | 20.72% | 310.29% |
| Capital Expenditure | -99.29% | -94.56% | -146.36% | -194.85% | -116.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 65.43% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -207.65% | -361.91% | -97.00% | -382.18% | -498.04% |
| Cash from Investing | -11.68% | -187.85% | -125.61% | -232.87% | 39.94% |
| Total Debt Issued | -- | -- | -- | -- | -99.24% |
| Total Debt Repaid | -58.48% | 13.00% | -52.87% | 96.28% | 37.78% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -29.47% | -32.92% | -18.43% | -16.13% | -0.36% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -50.65% | -- | -11.61% | -- |
| Other Financing Activities | -- | -- | -23.97% | 23.97% | -- |
| Cash from Financing | -38.65% | -46.84% | -23.17% | -2.91% | -250.60% |
| Foreign Exchange rate Adjustments | 73.97% | 1.75% | -130.43% | -356.65% | -351.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.68% | 73.70% | -29.05% | -12.41% | 27.36% |
